Chemical Business Newsbase articles from June 2001

Chemical Business Newsbase archives from June 2001

PHARMA JAPAN: Toyama Chemical: marking net loss of Yen 2.8 bn: fiscal year ending Mar 2001.
June 29, 2001... For the fiscal year ending in Mar 2001, Toyama Chemical's sales declined 21.6%, compared with the year-earlier period to Yen 36,672 M, with a net loss of Yen 2777 M. The principal reasons for the loss are the withdrawal of Sarpul...

PHARMA JAPAN: Ando Chemical Works: operating losses for two consecutive years.
June 29, 2001... In fiscal year ending in Mar 2001, Ando Chemical Works recorded consolidated sales of Yen 25 ,877 M (down 0.8% compared with the year-earlier period), operating losses of Yen l6l M, (ordinary profits of Yen 47 M (down 66.4%), and net profits...

CHEMISCH2WEEKBLAD: Dutch subsidy for Byk Gulden research into smoker's disease.
June 29, 2001... The Dutch environment ministry's Bedrijfsgerichte Technologie Stimulering (BTS) has granted a subsidy of HFL 0.65 M to the German pharmaceuticals company Byk Gulden Lomberg for an HFL 2 M research project into chronic obstructive pulmonary...

ASIAN CHEMICAL NEWS: TPI finalises $53 M Polene debt sale.
June 29, 2001... Thai Petrochemical Industry's (TPI's) activities to settle its $2.8 bn of debt are reported. By Oct 2001, the company should have sold its power plant. By the end of Jul, TPI hopes to have raised $100 M, in order to increase refinery...

CHEMISCH2WEEKBLAD: SITA created from waste processing merger.
June 29, 2001... The Dutch waste processing companies BFI and Watco are merging to form SITA. The new firm will be the market leader in the Netherlands with a turnover of around EUR 450 M. It will carry out the environmentally friendly processing of...

ASIAN CHEMICAL NEWS: PE/PP merger study aims to draw partners.
June 29, 2001... Foreign investors will be asked to invest in polyethylene and polypropylene mergers planned by Japan Polychem (JPC) with Japan Polyolefins (JPO) and Chisso Corp. ExxonMobil has been identified as a potential partner in the polyethylene...

ASIAN CHEMICAL NEWS: IOC eyes two more IPCL units.
June 29, 2001... By the end of Aug 2001, the Indian government is expected to have initiated the bidding process for its holdings in Indian Petrochemicals Corp Ltd's (IPCL's) Nagothane and Gandar complexes. Indian Oil Corp (IOC) is expected to bid for the...

ASIAN CHEMICAL NEWS: IOC may buy just Haldia cracker.
June 29, 2001... Indian Oil Corp (IOC) is planning to assess valuations of Haldia Petrochemicals Ltd's 420,000 tonne/y cracker and downstream facilities before deciding how much of the complex it will purchase.

ASIAN CHEMICAL NEWS: Japan 'unaffected' by Chinese antidumping duty.
June 29, 2001... Although China imposed antidumping duties on acrylate shipments from Japan and the US for a five-year period from Nov 2000, Japanese producers claim they are not affected by the duty. Toagosei has dodged the 69% tariff by giving the...

ASIAN CHEMICAL NEWS: Hyosung and YNCC strike losses climb to Won 82 bn.
June 29, 2001... A 12-day strike (25 May-5 Jun 2001) at Hyosung Corp's facilities in Ulsan, Korea, has cost the company Won 42.90 bn. Production of nylon tyre cord, nylon filament and polyester tyre cord were affected. A strike at Yeochun NCC's...

ASIAN CHEMICAL NEWS: Thai govt will not shut NFC, says ceo.
June 29, 2001... The acting chief executive officer of National Fertiliser Co (NFC) intends to follow the Thai government's six month plan to save the company from closure. NFC has a debt burden of Baht 8.6 bn with a further Baht 1.76 bn of interest...

ASIAN CHEMICAL NEWS: Ibra and Holdiko sign BOPP sale deals.
June 29, 2001... Holdiko Perkasa has sold its holdings in its bi-axially oriented polypropylene (BOPP) film joint ventures to its partner, Jefflyne Golden Holdings. Jefflyne paid $29.17 M for 1 77% holding in Indopoly Swakarsa Industry of Indonesia, and...

ASIAN CHEMICAL NEWS: China unlikely to cut tariffs.
June 29, 2001... An anticipated 2% reduction in petrochemical import tariffs has not been announced by the Chinese government as had been expected. It had been thought that a reduction would be made prior to China's entry into the World Trade Organisation...

ASIAN CHEMICAL NEWS: AV Birla MRPL stake for HPCL.
June 29, 2001... In India, AV Birla is selling its 37.38% stake in Mangalore Refineries & Petrochemicals Ltd (MRPL) to Hindustan Petroleum Corp Ltd (HPCL). HPCL already has a 37.38% holding in MRPL, which owns a refinery in Mangalore with a capacity of 9...

ASIAN CHEMICAL NEWS: Dow takes stake in China chemical plant.
June 29, 2001... As part of Rohm & Haas' $1 bn sale of its agricultural chemicals operations to Dow Chemical, Dow AgroSciences will acquire Rohm & Haas' holding in a crop protection chemicals facility in Nantong, Jiangsu, China.

ASIAN CHEMICAL NEWS: AVC wants US PVC import rulings to stay.
June 29, 2001... The Australian customs department is currently reviewing antidumping duties placed on imports of PVC from the US. The tariffs were introduced in 1992 and are due to be withdrawn in Jan 2002. The only PVC producer in Australia,...

ASIAN CHEMICAL NEWS: Staying in the race.[3 tables].
June 29, 2001... Factors affecting the Japanese polyolefins industry are identified and discussed. The main issue facing the industry is improving and maintaining competitiveness, because, in domestic markets, import tariffs will be reduced to 6.5% in...

ASIAN CHEMICAL NEWS: Investing for the future: Nan Ya Plastics plans Chinese projects.
June 29, 2001... Some $1.5 bn of investment will be made in Kunshan, Jiangsu Province, China, by the electronic materials division of Nan Ya Plastics. In 2002, the company will open a copper clad laminate (CCL) plant with a capacity of 500,000...

ASIAN CHEMICAL NEWS: Nod for Shell LNG may aid petrochemicals.
June 29, 2001... The Indian government's approval for Royal Dutch Shell's LNG project in Hazira allows Shell to provide regasified gas to fertiliser and petrochemicals producers. This could benefit various companies, including Gujarat Narmada Valley...

ASIAN CHEMICAL NEWS: Liaoyang government plans 10 plants.
June 29, 2001... Ten chemicals projects are planned for the Liaoyang area of China. A $126.5 M methionine plant, a $50 M titanium dioxide facility (with 50,000 tonne/y of capacity), a $12 M trimellitic acid anhydride unit and a $10 M anhydrous...

ASIAN CHEMICAL NEWS: FPC board okays Mailiao expansion.
June 29, 2001... Plans to raise ethylene capacity at Formosa Petrochemical Corp's (FPC's) No2 cracker in Mailiao, Taiwan, have been approved by the company's board of directors. By the end of 2002, 400,000 tonne/y of capacity will have been added to the...

ASIAN CHEMICAL NEWS: DuPont technology for Toray homofibre.
June 29, 2001... A licensing agreement has been arranged between DuPont and Toray Industries, allowing Toray to produce fibres from DuPont's polymer Sorona 3GT. DuPont's technology will also be used by Toray to manufacture bicomponent fibre, containing...

ASIAN CHEMICAL NEWS: Tuntex delays No7 cracker.
June 29, 2001... Plans to build a 900,000 tonne/y ethylene cracker in Taiwan have been postponed for two years by Tuntex Petrochemicals. Reasons for the delay include low demand forecasts, increased competition and the state of Tuntex's finances. The...

ASIAN CHEMICAL NEWS: LG Chem plans to double ABS output.
June 29, 2001... Acrylonitrile butadiene styrene (ABS) capacity is to be raised at LG Chem's facilities in China and South Korea. By 2002, 80,000 tonne/y of capacity will have been added to the company's 350,000 tonne/y plant in Yosu, South Korea. In...

ASIAN CHEMICAL NEWS: ONGC gets environ go-ahead.
June 29, 2001... The Indian Ministry of Environment & Forests has approved Oil & Natural Gas Corp's (ONGC's) plans to build facilities to produce 136,500 tonne/y of special boiling point solvents and 20,000 tonne/y of food-grade hexane. The $16.7 M...

ASIAN CHEMICAL NEWS: Pidmco on NPC No 11 tender.
June 29, 2001... In Iran, the tendering process for National Petrochemical Co's 1 M tonne/y ethylene cracker (No 11 project) is being sorted out by Petrochemical Industries Development Management Co (Pidmco). The facility will be located in Assaluyen. ...

ASIAN CHEMICAL NEWS: Stella Jurong plant.
June 29, 2001... A 200,000 tonne/y hydrofluoric acid facility will be constructed in Pulau Merlimau, Jurong Island, Singapore, by Stella Chemifa Corp. The $26 M plant will be opened in Aug 2002.

ASIAN CHEMICAL NEWS: Caojing C2 JV signing delayed.
June 29, 2001... Feasibility studies, submitted by Sinopec Corp, BP and Shanghai Petrochemical Co for a 900,000 tonne/y cracker have yet to be approved by China's State Development & Planning Committee. The delay may result in the companies postponing the...

ASIAN CHEMICAL NEWS: NPIC, Basell agree on PP joint venture.
June 29, 2001... Saudi Polyolefins Co will be a new polypropylene joint venture between Basell (25% holding) and National Petrochemical Industrialisation Co (NPIC, 75% holding). The new company will open a 450,000 tonne/y polypropylene facility and a...

ASIAN CHEMICAL NEWS: PIM-2 may be relocated.
June 29, 2001... In Indonesia, the PIM-2 ammonia-urea project of Pupuk Iskandar Muda may be relocated from Aceh to Palembang because of political unrest in the region. Construction was halted in May 2001, when 20% of the project had been completed. ...

ASIAN CHEMICAL NEWS: South Korea strike hits fibre producers.
June 29, 2001... Synthetic fibre producers in South Korea have been affected by a nationwide strike which began on 12 Jun 2001. Production has ceased at Taekwang Industry's 250,000 tonne/y acrylonitrile plant and its 36,000 tonne/y nylon facility. ...

ASIAN CHEMICAL NEWS: SAR set to start benzene production.
June 29, 2001... In Jul 2001, Singapore Aromatics Recovery (SAR) will recommence the operation of its sulfolane unit. Benzene production is due to begin shortly and most of the 100-150,000 tonne/y of output will be purchased by Mitsui Phenol.

CHEMICAL AND ENGINEERING NEWS: Boost for ethanol.
June 29, 2001... The EPA has ruled that if California bans MTBE as a fuel additive, the state will have to switch to ethanol. California officials are predicting higher gasoline prices as a result of the decision and may challenge the EPA in court. ...

CHEMICAL AND ENGINEERING NEWS: Celera to buy Axys business.
June 29, 2001... Celera Genomics is to acquire Axys Pharmaceuticals for around $175 M in shares. The deal takes Celera from genomics and gene sequencing into drug development. Axys has concentrated on proteases and is developing small-molecule drugs...

CHEMICAL AND ENGINEERING NEWS: Noveon pares colorant line.
June 29, 2001... Noveon is to cease production of pigments and color products used in graphic arts and other imaging uses at Cincinnati. Around 80 jobs, or a third of the site's workforce will go. The company will still produce dyes used in food,...

CHEMICAL AND ENGINEERING NEWS: JM Huber to buy Noviant.
June 29, 2001... Huber is to acquire Noviant, the world's largest producer of carboxymethylcellulose from a group comprising Industri Kapital, Glide Buy-out Fund, and management. Noviant had sales of $175 M in 2000.

CHEMICAL AND ENGINEERING NEWS: LG expands ABS in Asia.
June 29, 2001... LG Chem is to increase its ABS capacity by 60% to 800,000 tonnes/y at plants at Yeosu, S Korea, and Ningbo, China. Investment will be $35 M, capacity at Yeosu reaching 430,000 tonnes/y, that at Ningbo 370,000 tonnes/y. Completion is...

CHEMICAL AND ENGINEERING NEWS: Business roundup: Malaysian plants nearing completion.
June 29, 2001... Two petrochemical joint venture ventures in Malaysia are almost complete. One is a gas cracker owned by Petronas (64%), Dow Chemical (24%), and Sasol (12%). The other is an LDPE plant owned by Sasol (40%), Petronas (40%), and DSM...

CHEMICAL AND ENGINEERING NEWS: Business roundup: Borealis in research and development deal.
June 29, 2001... Borealis has concluded a long-term research deal with the Laboratory of Polymer Technology at Abo Akademi University in Finland. The two will develop new catalysts and polyolefin grades using high-throughput experimentation.

CHEMICAL MARKET REPORTER: Canada's Alberta poised for strong petchem growth.
June 29, 2001... The Alberta government in Canada is targeting petrochemicals and their derivatives as a major growth sector. There is plenty of natural gas, making the province potentially one of the world's low-cost regions for the production of basic...

CHEMICAL MARKET REPORTER: DuPont to deploy pharma proceeds for stock buyback.
June 29, 2001... DuPont is to use the proceeds from the $7.8 bn sale of its drugs unit to Bristol-Myers Squibb Co to buy back stock, reduce debt, and make profit-adding acquisitions. DuPont will now focus on its core chemical operations and return...

CHEMICAL MARKET REPORTER: Is Europe on the edge.
June 29, 2001... US chemical stocks could be under threat from a slowdown in the European industrial economy and the effect of high natural gas prices on US chemical exports. The slowdown in Europe would have a negative effect on volume and prices of US...

CHEMICAL MARKET REPORTER: In DuPont Pharma, BMS gains early-stage pipeline; further acquisition might address portfolio's short-term weakness.
June 29, 2001... Bristol-Myers Squibb is increasing its concentration on drugs, shedding non-core units and strengthening its pipeline with the acquisition of DuPont Pharmaceuticals. DuPont's complementary portfolio could help bridge the gap between BMS'...

PRESS RELEASE: Gilead achieves primary endpoint in Phase III study of adefovir dipivoxil for chronic hepatitis B virus infection.
June 29, 2001... Gilead Sciences Inc (Gilead) announced interim 48-week data from a Phase III clinical trial (Study 437) evaluating the safety and efficacy of adefovir dipivoxil once daily as monotherapy compared to placebo in patients with chronic hepatitis...

PRESS RELEASE: Novartis announces largest diabetes and cardiovascular disease prevention trial with Starlix and Diovan.
June 29, 2001... Novartis Pharmaceuticals Corp announced plans to conduct the largest clinical trial to date on the prevention of Type II diabetes and cardiovascular disease. The NAVIGATOR (Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes...

PRESS RELEASE: Wyeth-Ayerst receives Not-Approvable letter from FDA for PMA for recombinant protein treatment for long-bone fractures.
June 29, 2001... Wyeth-Ayerst Laboratories (Wyeth-Ayerst) has received a Not-Approvable letter from the US Food and Drug Administration (FDA) regarding its Pre-Market Approval (PMA) application for a treatment of long-bone fractures utilizing a recombinant...

PRESS RELEASE: Abbott Laboratories, MediSense Products receives FDA clearance for new blood glucose monitoring test strip utilizing TrueMeasure advanced technology.
June 29, 2001... Abbott Laboratories, MediSense Products has received US Food and Drug Administration (FDA) marketing clearance for its newest test strip for blood glucose monitoring, utilizing MediSense Products' newly developed TrueMeasure technology. ...

PRESS RELEASE: Johnson & Johnson announces completion of merger with Alza Corp.
June 29, 2001... Johnson & Johnson and Alza Corp announced the completion of their previously announced merger. The transaction was completed on 22 Jun 2001 after Alza shareholders voted to approve the merger agreement with Johnson & Johnson at a meeting...

PRESS RELEASE: Schering-Plough provides update on manufacturing issues and FDA inspections of US manufacturing facilities.
June 29, 2001... Schering-Plough Corp reported that the US Food and Drug Administration (FDA) has completed inspections conducted during May 2001 and Jun 2001 at the company's manufacturing facilities in Kenilworth and Union, NJ, and Las Piedras and Manati,...

PRESS RELEASE: Results of EVIDENCE study of Rebif versus Avonex presented at the World Congress of Neurology in London.
June 29, 2001... Serono Laboratories (UK) Ltd (Serono) reported at the World Congress of Neurology in London, the results of the direct comparative EVIDENCE (EVidence for Interferon Dose-response: European-North American Comparative Efficacy Study) study...

PRESS RELEASE: Serono's marketing study misleading to doctors and people with MS; lacks scientific rigor, Biogen says.
June 29, 2001... Biogen Inc said that Serono continues to make misleading claims of superior efficacy in comparison to Biogen's multiple sclerosis (MS) drug, Avonex (interferon beta-1a), the world's leading treatment for the disease. Biogen also said...

PRESS RELEASE: Studies highlight latest research into obesity and anorexia nervosa.
June 29, 2001... Three studies presented in a press conference at ENDO 2001, the 83rd Annual Meeting of The Endocrine Society, which takes place in Denver, CO, 20 Jun-23 Jun 2001, examine the causes of obesity and the effects of anorexia nervosa on the human...

PRESS RELEASE: Entertainment celebrity Charytin introduces Hydron skincare to Mexico.
June 29, 2001... Hydron Technologies Inc (Hydron) has begun initial distribution of its exclusive skincare product line into Mexico, led by the famous Latin music and performance artist Charytin, "The Blond of America." Hydron has contracted Charytin as...

PRESS RELEASE: Study shows rapid-acting human insulin analog, insulin aspart, lowers risk of hypoglycemia at night.
June 29, 2001... A study in individuals with Type I diabetes provided evidence that the use of insulin aspart (rDNA origin) injection (brand name, NovoLog), a rapid-acting insulin analog, reduced by more than 70% the risk of severe nocturnal hypoglycemia when...

PRESS RELEASE: Studies show combination therapy of oral antidiabetic drug repaglinide and insulin sensitizers improves blood glucose control.
June 29, 2001... Results from two recently completed studies suggest combining the oral antidiabetic drug repaglinide (Prancing, called NovoNorm outside the USA) with an insulin sensitizer improves blood glucose control better than either drug alone. The...

PRESS RELEASE: Key research announced on treating Type 2 diabetes in high-risk ethnic populations.
June 29, 2001... Results from three new studies presented at the American Diabetes Association 61st Scientific Sessions show that insulin-sensitising Avandia, alone or in combination with other oral anti-diabetic therapy, significantly improved glycaemic...

PRESS RELEASE: Amaryl (glimepiride tablets) is preferable to glyburide as initial therapy for Type II diabetes.
June 29, 2001... Aventis Pharmaceuticals reported that Amaryl (glimepiride tablets) showed a reduced risk of early hypoglycemia after initial dose compared to glyburide, making it preferable as initial therapy for Type II diabetes patients, according to the...

PRESS RELEASE: Family to share their story of successful paediatric growth hormone treatment with needle-free delivery system at BIO 2001.
June 29, 2001... Cool.click is the first needle-free drug delivery system in the US exclusively for use with one brand of growth hormone, Saizen [somatropin (rDNA origin) for injection]. A family from Anaheim, CA, who uses cool.click will tell their...

PRESS RELEASE: Inhaled insulin (Exubera) allows more patients to reach recommended blood glucose levels than insulin injections, new data show.
June 29, 2001... More patients with Type II diabetes who were treated with inhaled insulin (Exubera) achieved the recommended blood glucose levels than patients who received only insulin injections, according to data presented at the American Diabetes...

PRESS RELEASE: Ford may take some tyres off list as acceptable replacements in recall.
June 29, 2001... Ford Motor Co (Ford) might take some of the tyres off its list of acceptable replacements in its recall of 13 M Firestone tyres as early as in third week of Jun 2001, Congressional sources tell Newsweek in the current issue. During...

PRESS RELEASE: Study shows oral antidiabetic drug repaglinide has unique mechanism of action.
June 29, 2001... A new in vitro study suggests the oral antidiabetic drug (OAD) repaglinide (Prandin, called NovoNorm outside the US), stimulates insulin secretion by the pancreas through a different mechanism than nateglinide and tolbutamide, OADs prescribed...

PRESS RELEASE: New clinical results announced showing dosing of pulmonary insulin in smokers and non-smokers.
June 29, 2001... The first carefully controlled clinical study examining the use of pulmonary insulin in both smokers and non-smokers using the AERx insulin Diabetes Management System (iDMS), has found the new insulin delivery route to be safe and effective....

PRESS RELEASE: Medarex and Epicyte Pharmaceutical announce collaboration to develop therapeutic antibodies.
June 29, 2001... Medarex Inc and Epicyte Pharmaceutical Inc (Epicyte) announced a collaboration for the joint discovery, development, and commercialisation of antibody-based products. Medarex plans to use its UltiMAb Human Antibody Development System to...

PRESS RELEASE: Neurogenetics Inc completes second-round financing.
June 29, 2001... Neurogenetics Inc announced the completion of $9 M in venture capital financing. The financing round included previous investors Alta Partners, Advent International and GIMV (Belgium), as well as new investors Novartis Venture Fund and...

PRESS RELEASE: SYN X Pharma warrants exercised in full by Genzyme Corp.
June 29, 2001... SYN X Pharma Inc announced that Genzyme Corp purchased 513,699 common shares of SYN X Pharma at a price of $7.3 for total proceeds of $3.75 M in association with the 22 May 2001 milestone of receiving US Patent No 6,235,489 for diagnosing and...

PRESS RELEASE: BioMarin files CTX to conduct clinical trial of Vibriolysin Topical to treat serious burns.
June 29, 2001... BioMarin Pharmaceutical Inc has filed a Clinical Trial Exemption (CTX) application with the Medicines Control Agency in the UK for permission to conduct a human clinical trial of Vibriolysin Topical in patients with serious burns. ...

PRESS RELEASE: Corgenix and Chugai Diagnostics Science sign technology licence.
June 29, 2001... Corgenix Medical Corp (Corgenix) has executed a technology licence agreement with Chugai Diagnostics Science Co Ltd (Chugai Diagnostics), a subsidiary of Chugai Pharmaceutical Co Ltd of Tokyo, Japan. The licence agreement provides...

PRESS RELEASE: Gliatech starts US study MRI re-evaluation.
June 29, 2001... Gliatech Inc has received permission from the Food and Drug Administration (FDA) and has initiated an independent re-evaluation of the magnetic resonance imaging (MRI) data from the US clinical study of Adcon-L. The re-evaluation will be...

PRESS RELEASE: NicOx and Biolipox enter into research collaboration.
June 29, 2001... NicOx SA announced the signature of a research and co-development agreement on a novel class of nitric oxide-releasing respiratory therapeutics with the Swedish research-based company Biolipox. The collaboration between the two companies...

PRESS RELEASE: EntreMed and the National Eye Institute team up to fight macular degeneration by blocking angiogenesis.
June 29, 2001... EntreMed Inc announced a two year Cooperative Research and Development Agreement (CRADA) with the National Eye Institute (NEI) to study the role that Panzem (2-methoxyestradiol) can play in treating the retinal angiogenesis that leads to...

PRESS RELEASE: dj Orthopedics' Alaron Surgical Division announces exclusive US distribution agreement with Biocomposites Ltd to supply Bilok composite ACL Interference screw.
June 29, 2001... dj Orthopedics LLC signed a distribution agreement with British-based biotech company Biocomposites Ltd that designates dj Orthopedics as the exclusive US supplier of the revolutionary Bilok ACL Interference screw. Alaron, the new...

PRESS RELEASE: Emisphere initiates clinical testing of oral insulin.
June 29, 2001... Emisphere Technologies Inc (Emisphere) has initiated the dosing phase of two clinical studies evaluating its proprietary oral delivery technology with insulin. The studies are being conducted in The Netherlands and in Israel. These...

PRESS RELEASE: Immunomedics presents interim results on its radiolabeled CD22 antibody for the treatment of non-Hodgkin's lymphoma.
June 29, 2001... Immunomedics Inc presented interim results on the use of CD22 antibodies for the therapy of non-Hodgkin's lymphoma (NHL) at a special seminar held at the 48th Annual Meeting of the Society of Nuclear Medicine, in Toronto, Canada. The...

PRESS RELEASE: BioSpecifics announces completion of construction for state of the art biopharmaceutical production facility.
June 29, 2001... BioSpecifics Technologies Corp (BioSpecifics) announced the completion of construction and commencement of first stage production runs at its advanced biopharmaceutical manufacturing facility. This dedicated facility was designed for...

PRESS RELEASE: Additional academic research labs adopt ActiveCyte to market their research innovations to the pharmaceutical industry.
June 29, 2001... Four additional leading academic research institutions have adopted the services of ActiveCyte to market innovative technologies and therapeutic agents more effectively and efficiently to major pharmaceutical and biotechnology companies. ...

PRESS RELEASE: AstraZeneca announces Exanta (ximelagatran) as trade name of investigational oral direct thrombin inhibitor.
June 29, 2001... AstraZeneca announced it has adopted the trade name Exanta for its investigational anticoagulant medication ximelagatran. Exanta is being studied in Phase III trials for the treatment of deep vein blood clots, for the prevention of blood...

PRESS RELEASE: Genasense shown to be highly synergistic with additional anticancer drugs at European Haematology Meeting.
June 29, 2001... Genta Inc announced the presentation of two scientific studies that documented the synergy between Genta's lead antisense compound, Genasense, with drugs that are used in the company's ongoing, late-stage, clinical trials in patients with...

PRESS RELEASE: Irbesartan study demonstrates protection against progression of kidney disease in patients with high blood pressure and Type II Diabetes.
June 29, 2001... Important new study results from a landmark programme demonstrate that the angiotensin II receptor blocker, irbesartan, a high blood pressure medication, protected against the progression of kidney disease in people with hypertension and Type...

PRESS RELEASE: Nabi to sell majority of its antibody collection business to CSL Ltd for $152 M in cash.
June 29, 2001... Nabi announced that the company has signed a definitive agreement to sell the operating assets of a majority of its antibody collection business to CSL Ltd. The agreement covers 47 of Nabi's current 56 antibody collection centres and its...

PRESS RELEASE: Cauley Geller Bowman & Coates LLP announces class action lawsuit against Chronimed Inc seeking damages on behalf of investors.
June 29, 2001... The Law Firm of Cauley Geller Bowman & Coates, LLP announced that a class action has been filed in the US District Court for the District of Minnesota on behalf of purchasers of Chronimed Inc. The complaint charges Chronimed and certain...

PRESS RELEASE: Fred Hutchinson Cancer Research Center study suggests genetic variability may predict severity of side effects from methotrexate, a common chemotherapy drug.
June 29, 2001... Nearly 50% of all Americans carry a genetic mutation that to some degree interferes with their ability to metabolise folate, a B vitamin found in fruits, grains, and dark green, leafy vegetables. The study involved researchers from the...

PRESS RELEASE: Barrick and Homestake announce merger plan. [1 table].
June 29, 2001... Barrick Gold Corp (Barrick) and Homestake Mining Co (Homestake) announced plans to merge, creating a new leader in the gold industry - both in quality and scale. The combined company is expected to have a market capitalization of $9 bn,...

PRESS RELEASE: Chevron Phillips Chemical Co and Qatar Petroleum announce construction of petroleum plant in Qatar.
June 29, 2001... Chevron Phillips Chemical Co LLC and Qatar Petroleum of Qatar have signed a joint venture agreement for the development of a world-scale petrochemical company in the State of Qatar. The petrochemical plant will be built in Ras Laffan,...

PRESS RELEASE: Tessag and Syntroleum update sweetwater gas-to-liquids project.
June 29, 2001... Syntroleum Corp and Tessag INA issued a project update that the recent design changes that have delayed finalization of the EPC contract for Syntroleum's sweetwater gas-to-liquids project, under development in Australia, are now agreed. ...